DE2733951A1 - Alpha, omega-diaminoalkylenverbindungen - Google Patents

Alpha, omega-diaminoalkylenverbindungen

Info

Publication number
DE2733951A1
DE2733951A1 DE19772733951 DE2733951A DE2733951A1 DE 2733951 A1 DE2733951 A1 DE 2733951A1 DE 19772733951 DE19772733951 DE 19772733951 DE 2733951 A DE2733951 A DE 2733951A DE 2733951 A1 DE2733951 A1 DE 2733951A1
Authority
DE
Germany
Prior art keywords
group
general formula
compounds
compound
groups
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE19772733951
Other languages
German (de)
English (en)
Inventor
Graham John Durant
Charon Robin Ganellin
George Sidney Sach
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Smith Kline and French Laboratories Ltd
Original Assignee
Smith Kline and French Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith Kline and French Laboratories Ltd filed Critical Smith Kline and French Laboratories Ltd
Publication of DE2733951A1 publication Critical patent/DE2733951A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/69—Two or more oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/61—Halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/65—One oxygen atom attached in position 3 or 5
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/68—One oxygen atom attached in position 4

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DE19772733951 1976-07-28 1977-07-27 Alpha, omega-diaminoalkylenverbindungen Withdrawn DE2733951A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB3139276 1976-07-28

Publications (1)

Publication Number Publication Date
DE2733951A1 true DE2733951A1 (de) 1978-02-02

Family

ID=10322420

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19772733951 Withdrawn DE2733951A1 (de) 1976-07-28 1977-07-27 Alpha, omega-diaminoalkylenverbindungen

Country Status (9)

Country Link
US (4) US4139624A (enExample)
JP (1) JPS5315383A (enExample)
AU (1) AU2730377A (enExample)
BE (1) BE857220R (enExample)
DE (1) DE2733951A1 (enExample)
FR (1) FR2359838A1 (enExample)
LU (1) LU77854A1 (enExample)
NL (1) NL7708377A (enExample)
ZA (1) ZA774220B (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4219553A (en) * 1976-07-28 1980-08-26 Smith Kline & French Laboratories Limited Alkoxy pyridyl substituted alkanes
FR2446829A1 (fr) 1978-11-16 1980-08-14 Glaxo Group Ltd Derives de polymethylene disubstitues en alpha, omega, procede pour leur preparation et compositions pharmaceutiques les contenant
JPH0610632B2 (ja) * 1985-05-10 1994-02-09 株式会社日立製作所 音響インテンシティワットメ−タ
JPS63120228A (ja) * 1986-11-10 1988-05-24 Yoshida Kogyo Kk <Ykk> 音の方向成分分離測定方法
JPH01196521A (ja) * 1988-02-01 1989-08-08 Hitachi Ltd 振動インテンシテイワットメータ
WO2022034121A1 (en) 2020-08-11 2022-02-17 Université De Strasbourg H2 blockers targeting liver macrophages for the prevention and treatment of liver disease and cancer

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4013659A (en) * 1973-07-13 1977-03-22 Smith Kline & French Laboratories Limited Certain n,n'-disubstituted guanidine compounds and their use
US4062967A (en) * 1974-02-07 1977-12-13 Smith Kline & French Laboratories Limited Bis-guanidino-alkane compounds
GB1493931A (en) * 1974-02-07 1977-11-30 Smith Kline French Lab Guanidines isothioureas and thioureas
GB1533380A (en) * 1974-09-02 1978-11-22 Smith Kline French Lab Process for the preparation of heterocyclic substituted thioureas and h-cyanoguanidines
US4154838A (en) * 1975-07-31 1979-05-15 Smith Kline & French Laboratories Limited Alkoxy pyridine
GB1564502A (en) * 1975-07-31 1980-04-10 Smith Kline French Lab Guanidines thioureas and 1,1-diamino-2-nitroethylene derivatives

Also Published As

Publication number Publication date
NL7708377A (nl) 1978-01-31
FR2359838A1 (fr) 1978-02-24
US4282224A (en) 1981-08-04
BE857220R (fr) 1978-01-27
US4269844A (en) 1981-05-26
US4374839A (en) 1983-02-22
ZA774220B (en) 1978-06-28
AU2730377A (en) 1979-02-15
US4139624A (en) 1979-02-13
LU77854A1 (enExample) 1977-10-24
JPS5315383A (en) 1978-02-13

Similar Documents

Publication Publication Date Title
DE2344779C3 (de) N-Cyan-N&#39;-methyl-N&#39;&#39;-${2-[(5-methyl-imidazol-4-yl)-methylthio]-äthyl}-guanidin, seine Salze mit Säuren und seine Verwendung als Histamin-H↓2↓-Receptor-Antagonist
DE2211454C3 (enExample)
DE2406166A1 (de) Sulfoxide, ihre salze mit saeuren, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
CH630369A5 (de) Verfahren zur herstellung von neuen pyrazincarboxamiden.
DE2423813A1 (de) 1,1-diaminoaethylenderivate, ihre salze, verfahren zu ihrer herstellung und arzneimittel
DE2528639A1 (de) Harnstoff-derivate, verfahren zu ihrer herstellung und arzneimittel
DE2433625A1 (de) Harnstoff-derivate, verfahren zu ihrer herstellung und arzneimittel
DE3005786A1 (de) Cyanoguanidinderivate und verfahren zu deren herstellung
CA1068711A (en) Preparation of alkoxypyridyl derivatives which are histamine h2-antangonists
DE2504794A1 (de) Alpha, omega-diamino- oder -dithioalkylenverbindungen
DE2344833C2 (de) 5-Methylimidazol-4-ylmethylthioäthylguanidine und ihre Verwendung als Histamin-H &amp;darr;2&amp;darr;-Receptor-Antagonisten
DE2604056A1 (de) Thiocarbaminsaeure-derivate
DE2847792C2 (enExample)
DE2950838A1 (de) Neue thiazolylmethylthioderivate, verfahren zu deren herstellung und arzneimittel
DE2733951A1 (de) Alpha, omega-diaminoalkylenverbindungen
DE2819874A1 (de) Bisamidine, verfahren zu ihrer herstellung und ihre verwendung als histamin- h tief 2 - receptor-antagonisten
DE1445675B2 (de) Pyridylharnstoffe und verfahren zu ihrer herstellung
DE2733952A1 (de) Alpha, omega-diaminoalkylenverbindungen
DE2733953A1 (de) Alpha,omega-diaminoalkylenverbindungen
DE2634432A1 (de) Sulfoxide, ihre salze mit saeuren, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE2811477A1 (de) 1,2,4-triazin-5-on-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
CH626069A5 (en) Process for the preparation of substituted imidazoles
DE3336410A1 (de) Sulfenamidderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DD210909A5 (de) Verfahren zur herstellung von substituierten 3,4-diamino-1,2,5-thiadiazolverbindungen
US4219553A (en) Alkoxy pyridyl substituted alkanes

Legal Events

Date Code Title Description
8141 Disposal/no request for examination